UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease

Survey of ophthalmology, 2011-03, Vol.56 (2), p.95-113

Tolentino, Michael, MD

2011

Volltextzugriff (PDF)

Investigational drugs in clinical trials for macular degeneration

Expert opinion on investigational drugs, 2022-10, Vol.31 (10), p.1067-1085

2022

Volltextzugriff (PDF)

Drugs in Phase II clinical trials for the treatment of age-related macular degeneration

Expert opinion on investigational drugs, 2015-02, Vol.24 (2), p.183-199

2015

Volltextzugriff (PDF)

Current and investigational drugs for the treatment of diabetic retinopathy

Expert opinion on investigational drugs, 2016-09, Vol.25 (9), p.1011-1022

2016

Volltextzugriff (PDF)

Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial

Ophthalmology (Rochester, Minn.), 2016-10, Vol.123 (10), p.2232-2247

2016

Volltextzugriff (PDF)

Current molecular understanding and future treatment strategies for pathologic ocular neovascularization

Current molecular medicine, 2009-11, Vol.9 (8), p.973

Tolentino, Michael J

2009

Volltextzugriff (PDF)

Challenges of selecting pharmacotherapy for macular edema the need for better and combination therapies

Expert opinion on pharmacotherapy, 2019-03, Vol.20 (4), p.373-377

2019

Volltextzugriff (PDF)

Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2011-04, Vol.118 (4), p.626-635.e2

2011

Volltextzugriff (PDF)

The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2011-09, Vol.118 (9), p.1819-1826

2011

Volltextzugriff (PDF)

Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2

Ophthalmology (Rochester, Minn.), 2015-03, Vol.122 (3), p.545-554

2015

Volltextzugriff (PDF)

Safety of Intravitreal Ocriplasmin for Focal Vitreomacular Adhesion in Patients with Exudative Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2015-04, Vol.122 (4), p.796-802

2015

Volltextzugriff (PDF)

SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2011-07, Vol.118 (7), p.1364-1372

2011

Volltextzugriff (PDF)

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

American journal of ophthalmology, 2002-03, Vol.133 (3), p.373-385

2002

Volltextzugriff (PDF)

Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization

Retina (Philadelphia, Pa.), 2004-02, Vol.24 (1), p.132

2004

Volltextzugriff (PDF)

Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult Primate

Ophthalmology (Rochester, Minn.), 1996-11, Vol.103 (11), p.1820-1828

1996

Volltextzugriff (PDF)

SAT-444 Large-scale community outreach Fibroscan program to detect advanced fibrosis and cirrhosis for early detection of liver cancer

Journal of hepatology, 2024-06, Vol.80, p.S646-S646

2024

Volltextzugriff (PDF)

Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

JAMA ophthalmology, 2022-07, Vol.140 (7), p.692

2022

Volltextzugriff (PDF)

SCORE Study Report #11

Ophthalmology (Rochester, Minn.), 2011, Vol.118 (7), p.1364-1372

2011

Volltextzugriff (PDF)

Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis

Ophthalmic surgery, lasers & imaging, 2007-03, Vol.38 (2), p.164

2007

Volltextzugriff (PDF)

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

JAMA ophthalmology, 2017-06, Vol.135 (6), p.639

2017

Volltextzugriff (PDF)

Pharmacological evidence for the role of RAR in axon guidance and embryonic development of a protostome species

Genesis (New York, N.Y. : 2000), 2019-07, Vol.57 (7-8), p.e23301-n/a

2019

Volltextzugriff (PDF)

Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT

Retina (Philadelphia, Pa.), 2003-06, Vol.23 (3), p.307-314

2003

Volltextzugriff (PDF)

Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration

Retina (Philadelphia, Pa.), 2002-12, Vol.22 (6), p.683-690

2002

Volltextzugriff (PDF)

Assessing Appropriateness of CT and MRI Referrals for Headache and Lumbar: A Canadian Perspective on Patient-Centered Referrals

Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.506-513

2019

Volltextzugriff (PDF)

Giant cell angiofibroma of the orbit and eyelid

Ophthalmology (Rochester, Minn.), 1999-06, Vol.106 (6), p.1223-1229

1999

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

KollektionElektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

KollektionOxford Journals

PublikationsformBuchkapitel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(81)
Tagungsberichte
(5)

Sprache

Englisch
(86)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease

Investigational drugs in clinical trials for macular degeneration

Drugs in Phase II clinical trials for the treatment of age-related macular degeneration

Current and investigational drugs for the treatment of diabetic retinopathy

Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial

Current molecular understanding and future treatment strategies for pathologic ocular neovascularization

Challenges of selecting pharmacotherapy for macular edema the need for better and combination therapies

Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema

The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema

Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2

Safety of Intravitreal Ocriplasmin for Focal Vitreomacular Adhesion in Patients with Exudative Age-Related Macular Degeneration

SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization

Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult Primate

SAT-444 Large-scale community outreach Fibroscan program to detect advanced fibrosis and cirrhosis for early detection of liver cancer

Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

SCORE Study Report #11

Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

Pharmacological evidence for the role of RAR in axon guidance and embryonic development of a protostome species

Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT

Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration

Assessing Appropriateness of CT and MRI Referrals for Headache and Lumbar: A Canadian Perspective on Patient-Centered Referrals

Giant cell angiofibroma of the orbit and eyelid

Aktive Filter

Suchergebnisse filtern